INTRODUCTION
PCR-based whole-genome amplification (WGA) has the goal of generating microgram quantities of genome-representative DNA from picogram or nanogram amounts of starting material. This amplification should introduce little, or ideally no, representational bias. Unlike other techniques for WGA, PCR-based methods are generally less affected by DNA quality and are more applicable to DNA extracted from various sources (fixed and fresh tissues). The degenerate-oligonucleotide-primed PCR (DOP-PCR) method described here allows complete genome coverage in a single reaction. In contrast to the pairs of target-specific primer sequences used in traditional PCR, only a single primer, which has defined sequences at its 5′-end (containing an XhoI restriction site) and 3′-end and a random hexamer sequence between them, is used here. DOP-PCR comprises two different cycling stages. In stage 1 (low stringency), low-temperature annealing and extension in the first five to eight cycles occurs at many binding sites in the genome. The 3′-end of the primer binds at sites in the genome complementary to the 6-bp well-defined sequence at the 3′-end of the primer (~10 6 sites in the human genome). The adjacent random hexamer sequence (displaying all possible combinations of the nucleotides A, G, C, and T) can then anneal and tags these sequences with the DOP primer. In stage 2 (high stringency; >25 cycles), the PCR annealing temperature is raised, which increases priming specificity during amplification of the tagged sequence. DOP-PCR generates a smear of DNA fragments (200-1000 bp) that are visible on an agarose gel.
RELATED INFORMATION
When implementing WGA in the laboratory, it is important to assess the entire experimental process closely, including sample collection, fixation, storage, and initial DNA extraction procedures, as all of these factors can affect DNA quality and thus have some bearing on the selection of the WGA technique. When using WGA, it is important first to validate the method selected and to become proficient in the technique before applying it to actual samples. Irrespective of the method selected, it is essential to establish that the results generated from the amplified DNA are indistinguishable from the results obtained from the original genomic DNA.
The DNA that can be amplified by PCR-based WGA includes DNA extracted from fixed, frozen, or archival tissue; whole blood; buccal swabs; single cells; sorted chromosomes; and laser-capture microdissected tissue (for microdissection of tissues embedded in paraffin, the sections must be deparaffinized prior to microdissection). Genomic DNA may be extracted using a variety of commercially available methods such as the QIAamp DNA mini-kit (QIAGEN). Fixation of tissues can introduce sequence variations and reduce overall DNA quality. When studying such tissues, prior examination of the DNA by agarose gel electrophoresis will help determine the DNA quality. The amplified DNA produced is suitable for a range of downstream genetic assays and thus has the H 2 O (nuclease-free; Promega) MgCl 2 (50 mM; Invitrogen) Orange loading dye (6X; Fermentas) Taq DNA polymerase (5 U/µL) and accompanying 10X PCR buffer (Invitrogen) <R>TBE buffer (1X diluted from a 10X stock at pH 8; may also be obtained from Sigma) Thermosequenase (5 U/µL) and accompanying 10X Thermosequenase buffer (GE Healthcare) <R>Tris-Cl (10 mM at pH 8.0) containing 0.1 mM EDTA
Equipment

Electrophoresis apparatus Thermal cycler (MJ Research)
METHOD Stage 1: Low-Stringency Cycling
Low-stringency conditions allow low-temperature annealing and extension to occur at several binding sites across the genome.
Combine the following reagents:
2 µL Genomic DNA 1 µL 10X Thermosequenase buffer 1 µL DOP-PCR primer 0.1 µL dNTP mix 1 µL Thermosequenase Add nuclease-free H 2 O to a final volume of 10 µL.
potential for use not only in academic research, but also in commercial, forensic, and diagnostic laboratories.
DOP-PCR was first described by Telenius et al. (1992 ii. Resolve the aliquot by Agarose Gel Electrophoresis using a 1% agarose gel containing 20 µg of ethidium bromide (10 mg/mL) per 100 mL of agarose, alongside a DNA size marker. 
CSH Protocols
TROUBLESHOOTING
Problem: There is amplification in the negative control.
[Step 7.ii]
Solution: Due to the manipulation of PCR products in all PCR-based WGA methods, the reactions can easily be contaminated. If negative controls produce a DNA smear, several steps can be tried to eliminate this:
• Repeat using fresh reagents.
• Use filtered tips to avoid introduction of contaminants via aerosol from the pipette.
• Physically separate the areas in the laboratory where reactions are set up. Prepare and pipette the PCR mixture at one bench, and then add the DNA to the reaction in a different location in the laboratory. Also, use different pipettes for reaction preparation and pipetting of DNA.
• Aliquot all reaction constituents; if an aliquot becomes contaminated, only that aliquot will be lost and not the entire stock.
Problem: Unpredictable amplification is observed.
Solution: A positive control (such as starting with 50 ng of good-quality genomic DNA) can be used to ensure that the reaction is working optimally. In addition:
• Store small aliquots of dNTPs and oligonucleotides, as repeated freeze/thaw cycles of a single stock can affect the integrity of these reagents and thereby affect the efficiency of WGA.
• The starting concentration of DNA is crucial. Best results are obtained when starting with 10 ng (or more) of DNA extracted from fresh tissue/blood or 100 ng of DNA extracted from fixed tissue. Lower amounts of DNA (<10 ng from fresh tissue or <100 ng from fixed tissue) will generate amplification products, but results obtained in downstream applications may not be faithful to the result that would have been obtained from nonamplified DNA.
• If a positive control PCR using 10-100 ng of good-quality, high-molecular-weight DNA produces good results, the assay problems are a product of the DNA sample under investigation. However, if the positive control does not amplify, it suggests a problem with the reaction constituents or the thermal cycling. In such cases, use fresh aliquots of reagents, and repeat the experiment. If the problem still persists, it may be necessary to order fresh reagents.
Problem:
The amplification smear contains smaller DNA fragments than expected.
[Step 7.ii]
Solution: The efficiency of amplification is dependent on the quality of the starting DNA, and the size of the amplification products is also template-dependent. Tissue fixation causes degradation of template DNA within the sample. If the template is degraded, as is DNA from formalin-fixed, paraffin-embedded material, the smear will be smaller in size. Unfortunately, there is no way of improving this; thus care must be taken when using such products for downstream applications, because there may be more bias in these samples. Although PCR-based WGA is tolerant to mild or moderate DNA degradation and will amplify DNA with an average length of~200 bp, in this case it is essential to use increased quantities of starting DNA (100 ng) to guarantee a satisfactory yield of final product. Moderate to severe degradation will reduce WGA efficiency and subsequently decrease the quality of results obtained in downstream applications.
Problem: There is insufficient DNA for downstream reactions.
[ 
DISCUSSION
DOP-PCR-amplified DNA has been widely used, but precise measurement of the amount of starting template DNA is important. A shortage of genomic DNA template sometimes leads to a lower reliability of results in downstream applications due to allele drop-out and representational bias. Good results have been obtained for array CGH (Peng et al. 2003) , for which DOP-PCR has been demonstrated to provide the most reliable results when using minute quantities of DNA (Ng et al. 2005) . Single-nucleotide polymorphism (SNP) typing (Bannai et al. 2004 ) and microsatellite genotyping (Cheung and Nelson 1996) have demonstrated that a large proportion of the genome can be amplified by DOP-PCR. However, there is some debate as to whether there is preferential amplification of shorter alleles (Grant et al. 2002) . It is important to take these points into consideration when using DOP-PCR-amplified DNA.
